ABBOTT LABORATORIES — Director's Dealing 2015

Feb 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-02-20

Reporting Person: Foltz Charles D (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-20	Common shares without par value	A	16728	—	Acquired	79471	Direct
2015-02-20	Common shares without par value	A	21276	—	Acquired	100747	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-20	Option (right to buy)	$47.00	A	117878	Acquired	2025-02-19	Common shares (117878)	Direct

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock units under the Abbott Laboratories 2009 Incentive Stock Program. The award has an 18 month cliff vesting term.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,293 on 2/20/16, 39,292 on 2/20/17, and 39,293 on 2/20/18.